Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
18/11/2024 | 14:06 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HSDT | Helius Medical Technologies Inc |
18/11/2024 | 14:01 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device | NASDAQ:HSDT | Helius Medical Technologies Inc |
18/11/2024 | 14:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Exploration of Strategic Alternatives | NASDAQ:HSDT | Helius Medical Technologies Inc |
18/10/2024 | 14:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference | NASDAQ:HSDT | Helius Medical Technologies Inc |
14/10/2024 | 23:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece | NASDAQ:HSDT | Helius Medical Technologies Inc |
30/09/2024 | 14:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study | NASDAQ:HSDT | Helius Medical Technologies Inc |
16/08/2024 | 23:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | NASDAQ:HSDT | Helius Medical Technologies Inc |
12/08/2024 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
12/08/2024 | 22:05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
06/08/2024 | 22:36 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
24/07/2024 | 22:16 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:HSDT | Helius Medical Technologies Inc |
17/06/2024 | 13:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke | NASDAQ:HSDT | Helius Medical Technologies Inc |
31/05/2024 | 22:23 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NASDAQ:HSDT | Helius Medical Technologies Inc |
31/05/2024 | 22:21 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:HSDT | Helius Medical Technologies Inc |
30/05/2024 | 22:15 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:HSDT | Helius Medical Technologies Inc |
29/05/2024 | 15:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier | NASDAQ:HSDT | Helius Medical Technologies Inc |
20/05/2024 | 15:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts | NASDAQ:HSDT | Helius Medical Technologies Inc |
14/05/2024 | 22:15 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:HSDT | Helius Medical Technologies Inc |
13/05/2024 | 22:05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
10/05/2024 | 15:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
08/05/2024 | 22:56 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] | NASDAQ:HSDT | Helius Medical Technologies Inc |
07/05/2024 | 04:15 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering | NASDAQ:HSDT | Helius Medical Technologies Inc |
06/05/2024 | 15:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS®) | NASDAQ:HSDT | Helius Medical Technologies Inc |
24/04/2024 | 15:05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center | NASDAQ:HSDT | Helius Medical Technologies Inc |
03/04/2024 | 13:05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™ | NASDAQ:HSDT | Helius Medical Technologies Inc |
28/03/2024 | 21:05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:HSDT | Helius Medical Technologies Inc |
15/03/2024 | 12:05 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 | NASDAQ:HSDT | Helius Medical Technologies Inc |
12/03/2024 | 13:59 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke | NASDAQ:HSDT | Helius Medical Technologies Inc |
07/03/2024 | 13:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference | NASDAQ:HSDT | Helius Medical Technologies Inc |
04/03/2024 | 13:00 | GlobeNewswire Inc. | Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller | NASDAQ:HSDT | Helius Medical Technologies Inc |